1. Home
  2. MLEC vs AKTX Comparison

MLEC vs AKTX Comparison

Compare MLEC & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLEC
  • AKTX
  • Stock Information
  • Founded
  • MLEC 2008
  • AKTX N/A
  • Country
  • MLEC Luxembourg
  • AKTX United States
  • Employees
  • MLEC N/A
  • AKTX N/A
  • Industry
  • MLEC Blank Checks
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLEC Finance
  • AKTX Health Care
  • Exchange
  • MLEC Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • MLEC 23.9M
  • AKTX 32.8M
  • IPO Year
  • MLEC N/A
  • AKTX N/A
  • Fundamental
  • Price
  • MLEC $0.63
  • AKTX $1.08
  • Analyst Decision
  • MLEC
  • AKTX
  • Analyst Count
  • MLEC 0
  • AKTX 0
  • Target Price
  • MLEC N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • MLEC 10.8K
  • AKTX 26.4K
  • Earning Date
  • MLEC 03-12-2025
  • AKTX 02-24-2025
  • Dividend Yield
  • MLEC N/A
  • AKTX N/A
  • EPS Growth
  • MLEC N/A
  • AKTX N/A
  • EPS
  • MLEC N/A
  • AKTX N/A
  • Revenue
  • MLEC $5,625,124.00
  • AKTX N/A
  • Revenue This Year
  • MLEC $20.42
  • AKTX N/A
  • Revenue Next Year
  • MLEC $30.00
  • AKTX N/A
  • P/E Ratio
  • MLEC N/A
  • AKTX N/A
  • Revenue Growth
  • MLEC 521.53
  • AKTX N/A
  • 52 Week Low
  • MLEC $0.53
  • AKTX $0.90
  • 52 Week High
  • MLEC $3.25
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • MLEC 31.49
  • AKTX 43.34
  • Support Level
  • MLEC $0.53
  • AKTX $1.10
  • Resistance Level
  • MLEC $0.60
  • AKTX $1.33
  • Average True Range (ATR)
  • MLEC 0.05
  • AKTX 0.14
  • MACD
  • MLEC -0.02
  • AKTX -0.01
  • Stochastic Oscillator
  • MLEC 20.65
  • AKTX 5.97

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: